Perfil
Nathalie Riebel, formerly a Director of Clinical Operations at ImClone LLC, Director of Global Quality & Inspection at Eli Lilly & Co., Director of Clinical Operations at ICON plc, Director of Clinical Operations at GSK Plc, and currently serving as the Senior Vice President of Clinical Operations at PDS Biotechnology Corp.
Antiguos cargos conocidos de Nathalie Riebel.
| Empresas | Cargo | Fin |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Director Técnico/Científico/I+D | 01/12/2023 |
| ICON PUBLIC LIMITED COMPANY | Director Técnico/Científico/I+D | 01/03/2011 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Director Técnico/Científico/I+D | - |
| GSK PLC | Director Técnico/Científico/I+D | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ICON plc
ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
PDS Biotechnology Corp.
PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
- Bolsa de valores
- Insiders
- Nathalie Riebel
















